news Cilcare appoints Camille Rochmann as Evidence, Value & Access Senior Manager Learn More > 4 September 2025 Therapeutic Approaches to Hidden Hearing Loss: Celia Belline Featured on This Week in Hearing Learn More > 12 August 2025 Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders Learn More > 23 June 2025 Cilcare and CBSET publish White Paper on gene therapy for hearing loss in World Pharma Today Learn More > 20 May 2025 Cilcare launches a new study to explore hearing in patients with early-stage neurodegenerative diseases and identify new auditory biomarkers Learn More > 10 February 2025 Cilcare to exhibit at ARO 2025 and present at the PIHL Satellite Symposium Learn More > 4 February 2025 Cilcare appoints Dr. Preethi Sundaram to its Board of Directors Learn More > 30 January 2025 Cilcare appoints Dr. Bettina M. Cockroft as Chief Medical Officer Learn More > 17 January 2025 Cilcare completes a €40M series A Learn More > 4 December 2024 « Previous Page1 Page2 Page3 Page4 Page5 … Page28 Next »
Cilcare appoints Camille Rochmann as Evidence, Value & Access Senior Manager Learn More > 4 September 2025
Therapeutic Approaches to Hidden Hearing Loss: Celia Belline Featured on This Week in Hearing Learn More > 12 August 2025
Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders Learn More > 23 June 2025
Cilcare and CBSET publish White Paper on gene therapy for hearing loss in World Pharma Today Learn More > 20 May 2025
Cilcare launches a new study to explore hearing in patients with early-stage neurodegenerative diseases and identify new auditory biomarkers Learn More > 10 February 2025
Cilcare to exhibit at ARO 2025 and present at the PIHL Satellite Symposium Learn More > 4 February 2025
